Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

被引:13
|
作者
Voeller, Heinz [1 ,2 ]
Gitt, Anselm [3 ]
Jannowitz, Christina [4 ]
Karoff, Marthin [5 ]
Karmann, Barbara [4 ]
Pittrow, David [6 ]
Reibis, Rona [1 ,7 ]
Hildemann, Steven [4 ,8 ]
机构
[1] Klin See, Dept Cardiol, Rudersdorf, Germany
[2] Univ Potsdam, Rehabil Res Ctr, D-14469 Potsdam, Germany
[3] Heidelberg Univ, Inst Herzinfarktforsch, D-69115 Heidelberg, Germany
[4] MSD Sharp & Dohme GmbH, Med Affairs & Klin Forsch, Haar, Germany
[5] Klin Univ Witten Herdecke, Klin Konigsfeld Deutsch Rentenversicherung Westfa, Witten, Germany
[6] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[7] Cardiol Outpatient Clin, Potsdam, Germany
[8] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 1, Bad Krozingen, Germany
关键词
Cardiac rehabilitation; registry; chronic kidney disease; glomerular filtration rate; dyslipidemia; control rates; risk factor; lipids; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RENAL-FUNCTION; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; EXERCISE;
D O I
10.1177/2047487313482285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) is a frequent comorbidity among elderly patients and those with cardiovascular disease. CKD carries prognostic relevance. We aimed to describe patient characteristics, risk factor management and control status of patients in cardiac rehabilitation (CR), differentiated by presence or absence of CKD. Design and methods: Data from 92,071 inpatients with adequate information to calculate glomerular filtration rate (GFR) based on the Cockcroft-Gault formula were analyzed at the beginning and the end of a 3-week CR stay. CKD was defined as estimated GFR <60 ml/min/1.73 m(2). Results: Compared with non-CKD patients, CKD patients were significantly older (72.0 versus 58.0 years) and more often had diabetes mellitus, arterial hypertension, and atherothrombotic manifestations (previous stroke, peripheral arterial disease), but fewer were current or previous smokers had a CHD family history. Exercise capacity was much lower in CKD (59 vs. 92Watts). Fewer patients with CKD were treated with percutaneous coronary intervention (PCI), but more had coronary artery bypass graft (CABG) surgery. Patients with CKD compared with non-CKD less frequently received statins, acetylsalicylic acid (ASA), clopidogrel, beta blockers, and angiotensin converting enzyme (ACE) inhibitors, and more frequently received angiotensin receptor blockers, insulin and oral anticoagulants. In CKD, mean low density lipoprotein cholesterol (LDL-C), total cholesterol, and high density lipoprotein cholesterol (HDL-C) were slightly higher at baseline, while triglycerides were substantially lower. This lipid pattern did not change at the discharge visit, but overall control rates for all described parameters (with the exception of HDL-C) were improved substantially. At discharge, systolic blood pressure (BP) was higher in CKD (124 versus 121 mmHg) and diastolic BP was lower (72 versus 74 mmHg). At discharge, 68.7% of CKD versus 71.9% of non-CKD patients had LDL-C <100 mg/dl. Physical fitness on exercise testing improved substantially in both groups. When the Modification of Diet in Renal Disease (MDRD) formula was used for CKD classification, there was no clinically relevant change in these results. Conclusion: Within a short period of 3-4 weeks, CR led to substantial improvements in key risk factors such as lipid profile, blood pressure, and physical fitness for all patients, even if CKD was present.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [1] Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation
    Gitt, Anselm
    Jannowitz, Christina
    Karoff, Marthin
    Karmann, Barbara
    Horack, Martin
    Voeller, Heinz
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 265 - 274
  • [2] Chronic kidney disease as a cardiovascular risk factor
    Carmena, Rafael
    Ascaso, Juan F.
    Redon, Josep
    JOURNAL OF HYPERTENSION, 2020, 38 (11) : 2110 - 2121
  • [3] Chronic kidney disease: the forgotten cardiovascular risk factor
    Barrios, V.
    Escobar, C.
    Echarri, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (06) : 964 - 965
  • [4] CARDIAC REHABILITATION FOR PATIENTS WITH CHRONIC KIDNEY DISEASE
    Byrne, Gobnait
    Murphy, Fiona
    JOURNAL OF RENAL CARE, 2010, 36 : 154 - 162
  • [5] Evaluating Cardiovascular Risk in Chronic Kidney Disease Patients: A Biomarker Approach
    Gafor, Abdul Halim Abdul
    Mohd, Rozita
    Cader, Rizna
    Yen, Kong Wei
    Mohamad, Marlyn
    Shah, Shamsul Azhar
    Bain, Arbaiyah
    Kong, Norella C. T.
    SAINS MALAYSIANA, 2018, 47 (01): : 149 - 155
  • [6] Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
    Papademetriou, Vasilios
    Lovato, Laura
    Doumas, Michael
    Nylen, Eric
    Mottl, Amy
    Cohen, Robert M.
    Applegate, William B.
    Puntakee, Zubin
    Yale, Jean Francois
    Cushman, William C.
    KIDNEY INTERNATIONAL, 2015, 87 (03) : 649 - 659
  • [7] Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States
    Foster, Meredith C.
    Rawlings, Andreea M.
    Marrett, Elizabeth
    Neff, David
    Willis, Kerry
    Inker, Lesley A.
    Coresh, Josef
    Selvin, Elizabeth
    AMERICAN HEART JOURNAL, 2013, 166 (01) : 150 - +
  • [8] Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment?
    Scarpioni, Roberto
    Ricardi, Marco
    Melfa, Luigi
    Cristinelli, Luciano
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (06) : 361 - 368
  • [9] Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension
    Iwashima, Yoshio
    Horio, Takeshi
    Kamide, Kei
    Tokudome, Takeshi
    Yoshihara, Fumiki
    Nakamura, Satoko
    Ogihara, Toshio
    Rakugi, Hiromi
    Kawano, Yuhei
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (03) : 290 - 298
  • [10] Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease
    Burnier, Michel
    Damianaki, Aikaterini
    CIRCULATION RESEARCH, 2023, 132 (08) : 1050 - 1063